| Company/Division name | Oxford Pharmaceuticals |
| Type of work | Manufacturing |
| Reshoring category: | Transplant |
| Total number of jobs (added or to be added): | 61 |
| Number of manufacturing jobs outsourced domestically: | 61 |
| What product(s) and/or service(s) were outsourced domestically? | Manufacturing |
| Year reshoring announced: | 2014 |
| Year reshoring implemented or to be implemented: | 2016 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 29.4 |
| Country(ies) from which reshored: | United Kingdom |
| City reshored to: | Birmingham |
| State(s) reshored to: | AL |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | Manufacturing |
| What domestic positive factors made reshoring more attractive? | Government Incentives, Skilled workforce availability/training, Other, Free rent through partner |
